Barclays lowered the firm’s price target on MarketAxess to $215 from $225 and keeps an Equal Weight rating on the shares as part of a Q2 earnings preview. The analyst believes the brokers, asset managers and exchanges are continuing to get closer to a “normal” market environment, with the initial public offering and acquisition markets “showing signs of life,” setting the stage for a stronger second half of 2024 and first half of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKTX: